Klingen Life Sciences Private Limited
About Klingen Life Sciences Private Limited
Data last updated:
Klingen Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85320MH2017PTC303330. Its GSTIN is 27AAGCK8968A1Z9 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gurvendar Singh Rathod and Ranjeetsingh Gurudayalsingh Pawar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. G – 345 Dreams The Mall L.B.S. Marg Bhandup (West), Mumbai, Maharashtra, India – 400078.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.27 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹7.36 Lakh (net margin 2.2%) and EBITDA of ₹10.6 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 90% over three years and 59% over five years.
Court records list 1 case involving the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No. G – 345 Dreams The Mall L.B.S. Marg Bhandup (West), Mumbai, Maharashtra, India – 400078
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Klingen Life Sciences Private Limited
The main business activity of Klingen Life Sciences is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Klingen Life Sciences Private Limited FY 2025 filings available
Klingen Life Sciences Private Limited reported revenue of ₹3.27 Cr (up 54% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Klingen Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 59% over five years, including 54% growth in the latest year. EBITDA rose 92% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Klingen Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.6 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.36 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Klingen Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Klingen Life Sciences are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Klingen Life Sciences Private Limited
Klingen Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ruan Life Sciences Private Limited | ₹3.29 Cr (FY 2025) | •••• | •••• | 163.0% | •••• | Delhi, India |
| Shrine Lifesciences Private Limited | ₹3.28 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Gandhinagar, Gujarat, India |
| Diers Biomedical Solutions Private Limited | ₹3.28 Cr (FY 2024) | •••• | •••• | 157.0% | •••• | Delhi, India |
| Smilax Healthcare Private Limited | ₹3.28 Cr (FY 2025) | •••• | •••• | -89.0% | •••• | Jaipur, Rajasthan, India |
| Life Line Remedies (India) Private Limited | ₹3.27 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Klingen Life Sciences Private Limited this company | ₹3.27 Cr (FY 2025) | •••• | •••• | 54.0% | •••• | Mumbai, Maharashtra, India |
| Devendra Kirti Pharmachem Pvt. Ltd. | ₹3.27 Cr (FY 2024) | •••• | •••• | -31.0% | •••• | Palghar, Maharashtra, India |
| Nimbles Biotech Private Limited | ₹3.27 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Delhi, India |
| Ellis Pharma Private Limited | ₹3.27 Cr (FY 2025) | •••• | •••• | 152.0% | •••• | Ahmedabad, Gujarat, India |
| Eversure Industries Private Limited | ₹3.26 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Chennai, Tamil Nadu, India |
| Nutracare Formulations Private Limited | ₹3.26 Cr (FY 2025) | •••• | •••• | 298.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Klingen Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Klingen Life Sciences Private Limited
Klingen Life Sciences Private Limited is audited by LAD & NAGARAL ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| LAD & NAGARAL ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Klingen Life Sciences Private Limited
Klingen Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gurvendar Singh Rathod | Director | 06 Oct 2020 | 6 Years 0 Months | Current |
| Ranjeetsingh Gurudayalsingh Pawar | Director | 26 Dec 2017 | 8 Years 9 Months | Current |
Ownership and Shareholding of Klingen Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Klingen Life Sciences Private Limited
Klingen Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Klingen Life Sciences Private Limited
Klingen Life Sciences Private Limited has 1 court case on record: 1 where it is another party. All case is pending. Status as checked on 30 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Company is another party | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Klingen Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Klingen Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Klingen Life Sciences Private Limited
Klingen Life Sciences Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Manojkumar Tejraj Dagwal ceased to be Director on 15 Jun 2021.
Credit Ratings, Litigation & Regulatory Alerts for Klingen Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Klingen Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Klingen Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Klingen Life Sciences Private Limited
Klingen Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCK8968A1Z9 | Maharashtra | Active | 27 Feb 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Klingen Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Klingen Life Sciences Private Limited
Klingen Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 December 2017 (9+ years old) and is registered under CIN U85320MH2017PTC303330.
Klingen Life Sciences reported revenue of ₹3.27 Cr for FY 2025 (up 54% YoY).
Klingen Life Sciences has 2 current directors:
- Gurvendar Singh Rathod - Director
- Ranjeetsingh Gurudayalsingh Pawar - Director
Klingen Life Sciences reported a net profit of ₹7.36 Lakh (net margin 2.2%) and EBITDA of ₹10.6 Lakh (EBITDA margin 3.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Klingen Life Sciences is 90% over three years and 59% over five years. In the latest year (FY 2025) revenue rose 54%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Klingen Life Sciences is 27AAGCK8968A1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Klingen Life Sciences is U85320MH2017PTC303330. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Klingen Life Sciences has 1 court case on record. 1 is pending.
Klingen Life Sciences was incorporated on 26 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Klingen Life Sciences by revenue are Ruan Life Sciences Private Limited, Shrine Lifesciences Private Limited, Diers Biomedical Solutions Private Limited, Smilax Healthcare Private Limited, Life Line Remedies (India) Private Limited and 5 more, all in the Pharma industry (Formulations).
Manojkumar Tejraj Dagwal ceased to be Director on 15 Jun 2021. Gurvendar Singh Rathod was appointed as Director on 06 Oct 2020. Ranjeetsingh Gurudayalsingh Pawar was appointed as Director on 26 Dec 2017.